metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics Importance of detection of Strongyloides stercoralis DNA in fecal samples from p...
Información de la revista
Vol. 77.
(enero - diciembre 2022)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1703
Vol. 77.
(enero - diciembre 2022)
Original articles
Acceso a texto completo
Importance of detection of Strongyloides stercoralis DNA in fecal samples from patients with type 2 diabetes mellitus
Visitas
1703
Márcia Carolina Mazzaroa, Émelin Alves dos Santosa, Gessica Baptista de Melob, Priscila Duarte Marquesb, Laura Vilela Souzaa, Jefferson Elias-Oliveiraa, Bruna Campos da Silvaa, Ronaldo César Borges Gryschekb, Fabiana Martins de Paulab, Rosângela Maria Rodriguesa,
Autor para correspondencia
rosangela_rodrigues@ufj.edu.br

Corresponding author.
a Laboratório de Parasitologia, Universidade Federal de Jataí, Jataí, GO, Brazil
b Laboratório de Investigação Médica, Hospital de Clínicase Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo, Brazil
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (3)
Table 1. Socio-demographic (gender, age, employment, and education level) data of diabetes mellitus type 2 patients included in the study (n = 92).
Table 2. Socio-demographic (gender, age) and laboratory (random blood glucose, HbA1c, eosinophil) data of diabetes mellitus type 2 patients (n = 92) according to the molecular results.
Table 3. Characterization (Time DM2, random blood glucose, HbA1c, eosinophil, parasitological results) of diabetes mellitus type 2 patients according to the molecular results.
Mostrar másMostrar menos
Abstract
Objective

The association between diabetes and Strongyloides infection remains controversial. This study aimed to detect Strongyloides stercoralis DNA in the feces of patients with Diabetes Mellitus type 2 (DM2).

Methods

Fecal samples were analyzed via the Lutz, Rugai, and agar plate culture methods. PCR amplification was performed using two targets (PCR-genus and PCR-species) located on the S. stercoralis 18S ribosomal.

Results

The positivity for S. stercoralis using parasitological methods was 1.1%. PCR-genus (14.13%) demonstrated a higher positivity than PCR-species (9.78%).

Conclusion

The results confirm the greater positivity of the molecular diagnosis in relation to parasitological methods, reinforcing its use as an additional tool for the diagnosis of S. stercoralis infection in patients with DM2 living in endemic areas for this helminthiasis.

Keywords:
Strongyloidiasis
Diabetes mellitus
Parasitological diagnostic
Molecular diagnostic
Texto completo
Introduction

Strongyloides stercoralis infection is a neglected tropical disease1 that affects approximately 350 million people worldwide, particularly in tropical and subtropical regions.2,3 The ability of S. stercoralis to cause systemic infection is an important feature of this parasite that may lead to hyperinfection syndrome and disseminated strongyloidiasis with a mortality rate of up to 100%, especially in the presence of immunological impairment.4,5

Diabetes mellitus is a metabolic disease and a serious health problem. Type 2 Diabetes Mellitus (DM2) is the most common form in terms of the number of people affected, disability, and premature mortality.6 Evidence suggests that inadequate control of blood glucose levels in diabetic patients contributes to susceptibility to infections,7,8 including parasitic infections.9 However, the relationship between diabetes and Strongyloides infection remains controversial, with both positive10 and negative11 associations. Furthermore, the presence of clinical situations associated with immunosuppression, such as prolonged use of corticosteroids, can predispose individuals to the development of severe forms of S. stercoralis infections.12-15

The definitive laboratory diagnosis of S. stercoralis infection is based on the detection of larvae in the feces by microscopy. However, confirmation of infection is difficult because of the small number of larvae released in one's feces, particularly in the case of chronic infections.5 Molecular diagnosis is considered highly sensitive compared to parasitological methods and has been used to detect S. stercoralis infection in stool samples.16,17 In the context of S. stercoralis infection and diabetes, to date, very little research attention has focused on PCR for specific DNA detection.15,18 Thus, the present study aimed to detect S. stercoralis DNA in the feces of patients with DM2.

MethodsEthics statement

This study was approved by the Research Ethics Committee of the Federal University of Goiás, GO (protocol number 929.187/2015) and by Secretaria Municipal de Saúde de Jataí, GO. Informed consent was obtained from each patient before specimen collection.

Study population

This study was conducted in the municipality of Jataí, Brazil, which is located in southwestern Goiás State, 327 km from Goiânia (the capital of Goiás State) and 535 km from Brasilia (the capital of Brazil). The Health Care Network has 16 family health teams, corresponding to a population coverage of approximately 61.4%. The municipality of Jataí has an estimated population of 102,065 inhabitants.

The study was conducted from January 2015 to December 2016 and included patients with DM2 from the Diabetes Education and Control Program treated at the basic health unit of the municipality of Jataí, Goiás State. Inclusion criteria included any sex, age ≥30 years, diagnosis of DM2, use of insulin > 5 years, blood tests within the last two years, glycated Hemoglobin (HbA1c) > 6.5%, and no use of anthelmintic drugs in the last six months. Sociodemographic, clinical, and laboratory data were analyzed. All results were reported to the patients.

Parasitological diagnostic

Three fresh fecal samples were collected on alternate days from each individual and sent to the Laboratório de Parasitologia, Universidade Federal de Jataí, Goiás for processing and analysis. The samples were analyzed using the Lutz, Rugai, and agar plate culture methods. Aliquots of samples were immediately frozen at -20°C for molecular analysis.

Molecular diagnosticDNA extraction

The molecular analysis was carried out at Laboratório de Investigação Médica (LIM06) at the Hospital das Clínicas of the Universidade de São Paulo, São Paulo, Brazil. DNA was extracted using the QIAamp DNA Stool Mini Kit (Qiagen Hilden, Germany) according to the manufacturer's modified instructions. A pool of three fecal samples from each patient was prepared (∼600 mg), followed by washing with a 2% Polyvinylpolypyrrolidone (PVPP) solution (Sigma-Aldrich, San Luis, Missouri, USA) in phosphate buffer (0 0.01 M, Ph 7.2). The pellet was used for DNA extraction. The DNA was then quantified using a NanoDrop ND-100 UV-VIS V3.2.1 (NanoDrop Technologies, Wilmington, DE, USA).

Polymerase Chain Reaction (PCR)

PCR amplification was performed using two sets of primers located on the S. stercoralis 18S ribosomal: genus-specific (PCR-genus [392bp, forward 5′-AAAGATTAAGCCATGCATG-3′ and reverse 5′-GCCTGCTGCCTTCCTTGGA-3′])19 and species-specific (PCR-species [101bp, forward 5’-GAATTCCAAGTAAACGTAAGTCATTAGC-3’ and reverse 5′-TGCCTCTGGATATTGCTCAGTTC-3]).17

The PCR reaction tests were performed at a volume of 25 μL containing ∼50 ng μL−1 of DNA, 2.0 μg of BSA, 0.2 mM each of dNTP, 1.5 mM MgCl2, 2 pM of each primer, a 1 ×  PCR buffer, and 0.5 U Platinum® Taq DNA polymerase (Invitrogen™, Thermo Fisher Scientific Corporation, Waltham, MA, USA). Amplification cycles were composed of an initial denaturation at 94°C for 2 min, followed by 30 cycles of 94°C for 1 min (denaturation), 60°C for 1 min (annealing), 72°C for 1 min (extension), and 72°C for 2 min (final extension). PCR amplification was conducted using a Mastercycler EP Gradient S Thermocycler (Eppendorf, Hamburg, Germany). The products were separated by electrophoresis in 2% agarose gel containing SYBR Safe (Invitrogen™). Negative (PCR mix with no DNA template) and positive (DNA from the filariform larvae of S. stercoralis collected from positive agar plates) controls were included in each amplification run. PCR products with positive amplification for each target were submitted for sequencing, and the sequences obtained were evaluated using the Basic Local Alignment Search Tool (BLAST).

Data analysis

Descriptive analyses, including mean, Standard Seviation (SD), and percentages, were used to analyze the data.

ResultsSociodemographic data and parasitological diagnosis

A total of 92 patients with DM2 with a mean age of 62.3 years (±10.4) were included. Of these, 57 (61.96%) were women and 35 (38.04%) were men. Most of the patients were retired and had completed elementary school (Table 1).

Table 1.

Socio-demographic (gender, age, employment, and education level) data of diabetes mellitus type 2 patients included in the study (n = 92).

VariablesFrequency (%) 
GenderMale  35 (38.0%) 
Female  57 (62.0%) 
Age (years)30‒50  14 (15.2%) 
51‒70  57 (62.0%) 
> 70  21 (22.8%) 
EmploymentEmployee  18 (19.6%) 
Unemployed  12 (13.0%) 
Retired  50 (54.3%) 
Housewife  3 (3.3%) 
Autonomous  2 (2.2%) 
Pensioner  7 (7.6%) 
Educational levelNo formal  18 (19.6%) 
Primary  64 (69.6%) 
High school  7 (7.6%) 
Tertiary  3 (3.3%) 

Based on the parasitological results, positivity in association with DM2 was 32.61% (30/92) for parasites and intestinal commensals. Regarding helminths, only one case (1.1%) of S. stercoralis associated with DM2 was observed. In addition, the protozoans Blastocystis sp. (7.61%), Entamoeba coli (5.43%), Entamoeba hartmanni (4.35%), Endolimax nana (3.26%), Entamoeba histolytica (2.17%), and Giardia lamblia (1.1%) were observed.

Molecular diagnostic of the Strongyloides stercoralis infection

In the PCR-genus, target fragment amplification (∼392 bp) was observed in 14.13% (13/92) of patients with DM2 (Fig. 1). The sequences obtained from the PCR genus were of low quality. It is important to note that of the eight patients with positive results in the PCR-genus test, four showed parasitological positivity for Blastocystis sp./E. hartmanni or E. nana, and three were positive for E. nana or/and E. coli. Non-specific amplification (∼400‒500 bp) were observed in 18 samples. Among these, Blastocystis sp. and amoebas were identified in six samples by parasitological methods.

Figure 1.

Strongyloides DNA amplification by PCR-genus (392 bp) and PCR-species (101 bp). M, 100 bp Molecular weight marker, NC, Negative Control (PCR mix with water); PC, Positive Controls (S. stercoralis DNA larvae), and DNA of fecal samples from diabetes mellitus type 2 (lane 1, 2 or 3).

(0.07MB).

The PCR species showed a positivity rate of 9.78% (9/92) in patients with DM2 (Fig. 1). All PCR-species products were of high quality and confirmed the identity of S. stercoralis. Six samples with positive amplification by PCR-species (∼101 bp) showed specific amplification by PCR-genus (∼392 bp). The patients with parasitological results that were positive for S. stercoralis were positive only in the PCR-species test.

The mean values of glycemia (228.1 mg/dL), HbA1c (9.6%), and eosinophils (244.4% and 3.3%) were higher in the PCR-species tests for DM2-positive patients (Table 2). Patients with positive amplification results are shown in Table 3. The mean HbA1c level was 9.2%, and the time since diabetes diagnosis ranged from 4 to 25 years (mean 12.7).

Table 2.

Socio-demographic (gender, age) and laboratory (random blood glucose, HbA1c, eosinophil) data of diabetes mellitus type 2 patients (n = 92) according to the molecular results.

VariablePCR-  PCR-genus+  PCR-species+ 
Gender (n = 92)Male  26 
Female  44 
Age (years), Means ± SD63.2 ± 10.6  60.6 ± 8.3  58.3 ± 9.7 
Random blood glucose (mg/dL), Means ± SD211.4 ± 54.6  215.6 ± 51.7  228.1 ± 45.5 
HbA1c (%), Means ± SD9.0 ± 1.9  9.1 ± 1.8  9.6 ± 1.6 
Eosinophil, count (%), Means ± SD225.9 ± 224.0 (2.11 ± 3.14)  186.7±110.7 (2.6 ± 1.3)  244.4 ± 85.1 (3.3 ± 1.1) 
Table 3.

Characterization (Time DM2, random blood glucose, HbA1c, eosinophil, parasitological results) of diabetes mellitus type 2 patients according to the molecular results.

IDTime DM2 (years)Random blood glucose (mg/dL)HbA1c (%)EosinophilParasitological resultsMolecular results
Abs  (%)  PCR-genus  PCR-species 
232  12  206  8.8  57 
267  16  252  10.4  215  E. coli; E. nana; E. hartmanni 
295  10  223  9.4  195 
313  10  229  9.6  74  G. lamblia 
467  12  157  7.0  380  E. coli 
529  10  237  9.9  248  ‒ 
535  25  260  10.7  229  S. stercoralis 
587  15  189  8.2  55  E. nana 
637  15  318  11.0  83  ‒ 
639  12  312  12.5  268  ‒ 
676  14  186  8.1  320  E. coli 
847  10  194  8.4  101  ‒ 
943  12  197  8.5  271  ‒ 
1090  163  7.3  199  ‒ 
1094  13  246  10.2  247  ‒ 
1096  137  6.4  340  B. hominis; E. hartmanni 
1098  20  235  9.8  237  ‒ 
Discussion

Despite decades of investigation, the association between diabetes and Strongyloides infection remains controversial.10,11,20-22 Notably, strongyloidiasis is a neglected tropical disease and detection tests used in primary health care generally have low sensitivity.23 In addition, severe forms of strongyloidiasis have been reported in patients with diabetes, particularly when they have a condition associated with immunosuppression.13,14

Several parasitological techniques have been used for the diagnosis of S. stercoralis infection;4,5 however, the positivity rate is usually low, which can lead to false-negative results. In the present study, a 1.03% positivity rate for S. stercoralis was detected using parasitological techniques. Similar results were reported in a study of parasite frequencies in individuals with type 1 and type 2 diabetes in the Federal District of Brazil.24 In a review study,25 Brazil was characterized as a hyperendemic area, with an occurrence of 5.5% for S. stercoralis infection and an estimated frequency of 6.6% in the Midwest region.

Analysis of three stool samples per individual via the Rugai and agar plate culture methods ‒ techniques indicated for the search for larvae, can increase the detection of infection5,2 and these methods were employed in the present study. However, parasitological methods may fail to detect S. stercoralis, particularly in patients with chronic asymptomatic infection or minimal symptoms.5 It is worth noting that the patients included in the present study had no gastrointestinal symptoms.

It is understood that problems related to the sensitivity of parasitological methods for the detection of S. stercoralis can be solved using molecular methods.16,17,26 The detection of Strongyloides DNA in fecal samples has been the objective of research by several groups,27,28 particularly in cases of immunocompromised patients.29 However, the molecular diagnosis of S. stercoralis infection has been only minimally explored in the context of diabetes. In two recent case reports,15,18S. stercoralis infection in patients with diabetes was confirmed by PCR, suggesting a combination of parasitological and molecular methods for the diagnosis of helminthiasis.30

The present study is the first molecular analysis using two primers for the detection of specific Strongyloides DNA in fecal samples from patients with DM2. The positivity rates were 14.13% and 9.78% by PCR-genus and PCR-species, respectively. Regardless of the target, the positivity of PCR tests was higher than that of the parasitological methods, which has also been confirmed in other studies.28,29 The use of more sensitive methods to detect S. stercoralis infection in endemic areas such as Brazil can minimize the possible complications of severe strongyloidiasis in immunosuppressed patients.4,15

A fundamental step in the application of molecular methods is the choice of targets.26 The present results align with the data presented by Sitta et al.,27 who observed lower quality sequences obtained with the PCR-genus with S. stercoralis sequences present in the database. This can be explained by the amplification of different regions of the ribosomal gene, which is common in other organisms.31 Thus, the possibility of false positives cannot be ruled out, even with the visualization of amplification products with sizes similar to the target fragment, which supports the importance of sequencing.

Furthermore, PCR-species can act as an important tool in the molecular diagnosis of S. stercoralis infection, and the literature has indicated the high sensitivity and specificity of the species-specific primer.16,17,27 A study by Sitta et al.27 evaluating a panel of DNA obtained from fecal samples positive for S. stercoralis, positive for other parasitic infections, and negative, showed superior performance by the PCR-species versus PCR-genus. A species-specific primer was used in conventional PCR and real-time PCR for the detection of S. stercoralis DNA in fecal samples from transplant candidates, and the results showed good diagnostic performance.29 In the present study, all samples with positive amplification for PCR species were confirmed by sequencing to be S. stercoralis.

The potential limitations of this study include the small number of patients with diabetes analyzed and the absence of a control group, which could support the hypothesis of an association between S. stercoralis infection and DM2. However, the results reinforced the high sensitivity of molecular diagnosis in relation to parasitological in the detection of this helminth.

In conclusion, hyperinfection syndrome and dissemination of Strongyloides infection are associated with a high mortality rate, thus emphasizing the need for adequate screening tests to detect helminthiasis when a patient with diabetes has associated diseases that result in immunosuppression. Therefore, molecular methods can be considered an additional tool for the diagnosis of strongyloidiasis, particularly in patients with DM2 who live in areas in which S. stercoralis is endemic.

Authors' contributions

MCM and GBM: Conceptualization, writing (original draft, review, and editing); EAS, LVS, JEO, and BCS: supervision, writing, and visualization; PDM, RCBG, and FMM: writing (draft, review, and editing); FMP and RMR: conceptualization, supervision, writing (review and editing), and visualization.

Financial support

This work was supported by the researchers themselves.

Acknowledgments

The authors would like to thank the Secretaria Municipal de Saúde de Jataí, GO, for allowing us to conduct the research, and Dra. Fernanda de Mello Malta for support in the performance of the sequencing of the samples.

References
[1]
A Olsen, L van Lieshout, H Marti, T Polderman, K Polman, P Steinmann, et al.
Strongyloidiasis ‒ the most neglected of the neglected tropical diseases?.
Trans R Soc Trop Med Hyg, 103 (2009), pp. 967-972
[2]
S Puthiyakunnon, S Boddu, Y Li, X Zhou, C Wang, J Li, et al.
Strongyloidiasis an insight into its global prevalence and management.
PLoS Negl Trop Dis, 8 (2014), pp. e3018
[3]
PE Fleitas, M Travacio, H Martí-Soler, ME Socías, WR Lopez, AJ Krolewiecki.
The Strongyloides stercoralis-hookworms association as a path to the estimation of the global burden of strongyloidiasis: a systematic review.
PLoS Negl. Trop Dis., 14 (2020),
[4]
PB Keiser, TB Nutman.
Strongyloides stercoralis in the immunocompromised population.
Clin Microbiol Rev, 17 (2004), pp. 208-217
[5]
R Toledo, C Muñoz-Antoli, JG Esteban.
Strongyloidiasis with emphasis on human infections and its different clinical forms.
Adv Parasitol, 88 (2015), pp. 165-241
[6]
AF Costa, LS Flor, MR Campos, AF Oliveira, MFS Costa, RS Silva, et al.
Burden of type 2 diabetes mellitus in Brazil.
Cad Saúde Pública, 33 (2017),
[7]
ME Stegenga, SN van der Crabben, MC Dessing, JM Pater, PS van den Pangaart, AF de Vos, et al.
Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans.
Diabet Med, 25 (2008), pp. 157-164
[8]
S Knapp.
Diabetes and infection: is there a link? A mini-review.
Gerontol, 59 (2013), pp. 99-104
[9]
FO Akinbo, SO Olujobi, R Omoregie, E Egbe.
Intestinal parasitic infections among diabetes mellitus patients.
Biomark Genom Med, 5 (2013), pp. 44-47
[10]
E McGuire, C Welch, M Melzer.
Is Strongyloides seropositivity associated with diabetes mellitus? A retrospective case-control study in an East London NHS Trust.
Trans R Soc Trop Med Hyg, 113 (2019), pp. 189-194
[11]
R Hays, A Esterman, P Giacomin, A Loukas, R. McDermottf.
Does Strongyloides stercoralis infection protect against type 2 diabetes in humans? Evidence from Australian Aboriginal adults.
Diabetes Res Clin Pract, 107 (2015), pp. 355-361
[12]
CS Lam, MK Tong, KM Chan, YP. Siu.
Disseminated strongyloidiasis: a retrospective study of clinical course and outcome.
Eur J Clin Microbiol Infect Dis, 25 (2006), pp. 14-18
[13]
A Murali, G Rajendiran, K Ranganathan, S. Shanthakumari.
Disseminated infection with Strongyloides stercoralis in a diabetic patient.
Indian J Med Microbiol, 28 (2010), pp. 407-408
[14]
NM Azira, M. Zeehaida.
Strongyloides stercoralis hyperinfection in a diabetic patient: case report.
Trop Biomed, 27 (2010), pp. 115-119
[15]
M Sharifdini, A Hesari, SA Mahdavi, A Alipour, EB Kia.
Strongyloides stercoralis hyperinfection in an unconscious diabetic patient with dermatomyositis.
Indian J Path Microbiol, 61 (2018), pp. 109-112
[16]
RJ Ten Hove, M van Esbroeck, T Vervoort, J van den Ende, L van Lieshout, JJ Verweij.
Molecular diagnostics of intestinal parasites in returning travellers.
Europ J Clin Microbiol Infect Dis, 28 (2009), pp. 1045-1053
[17]
JJ Verweij, M Canales, K Polman, J Ziem, EA Brienen, AM Polderman, et al.
Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR.
Trans R Soc Trop Med Hyg, 103 (2009), pp. 342-346
[18]
EJ Won, J Jeon, YI Koh, DW Ryang.
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy.
Korean J Parasitol, 53 (2015), pp. 223-226
[19]
M Dorris, ME Viney, ML. Blaxter.
Molecular phylogenetic analysis of the genus Strongyloides and related nematodes.
Int J Parasitol, 32 (2002), pp. 1507-1517
[20]
A Rajamanickam, S Munisankar, Y Bhootra, C Dolla, K Thiruvengadam, TB Nutman, et al.
Metabolic consequences of concomitant Strongyloides stercoralis infection in patients with type 2 diabetes mellitus.
Clin Infect Dis, 69 (2019), pp. 697-704
[21]
BR Shah, JE. Hux.
Quantifying the risk of infectious diseases for people with diabetes.
Diabetes Care, 26 (2003), pp. 510-513
[22]
SC Mendonça, MR Gonçalves-Pires, RM Rodrigues, AJ Ferreira, JM Costa-Cruz.
Is there an association between positive Strongyloides stercoralis serology and diabetes mellitus?.
[23]
MD Dong, N Karsenti, R Lau, F Ralevski, K Cheema, L Burton, et al.
Strongyloidiasis in Ontario: Performance of diagnostic tests over a 14-month period.
Travel Med Infect Dis, 14 (2016), pp. 625-629
[24]
ER Machado, NO Matos, SM Rezende, D Carlos, TC Silva, L Rodrigues, et al.
Host-parasite interactions in individuals with type 1 and 2 diabetes result in higher frequency of Ascaris lumbricoides and Giardia lamblia in type 2 diabetic individuals.
J Diabetes Res, 2018 (2018),
[25]
FM Paula, JM. Costa-Cruz.
Epidemiological aspects of strongyloidiasis in Brazil.
Parasitology, 138 (2011), pp. 1331-1340
[26]
SS Wong, KS Fung, S Chau, RW Poon, SC Wong, KY. Yuen.
Molecular diagnosis in clinical parasitology: when and why?.
Exp Biol Med. (Maywood), 239 (2014), pp. 1443-1460
[27]
RB Sitta, FM Malta, JR Pinho, PP Chieffi, RC Gryschek, FM. Paula.
Conventional PCR for molecular diagnosis of human strongyloidiasis.
Parasitology, 141 (2014), pp. 716-721
[28]
N Van De, P Minh Ngoc, L Van Duyet, S Mas-Coma.
Strongyloidiasis in northern Vietnam: epidemiology, clinical characteristics and molecular diagnosis of the causal agent.
Parasit Vectors, 12 (2019), pp. 515
[29]
FM Paula, FM Malta, PD Marques, GB Melo, MA Corral, M Gottardi, et al.
Molecular diagnosis of Strongyloides stercoralis among transplant candidates.
Transp Infect Dis, 20 (2018), pp. e12909
[30]
LF Wang, L Xu, SQ Luo, H Xie, W Chen, ZD Wu, et al.
Diagnosis of Strongyloides stercoralis by morphological characteristics combine with molecular biological methods.
Parasitol Res, 116 (2017), pp. 1159-1163
[31]
NM Marra, F Chiuso-Minicucci, GC Machado, SF Zorzella-Pezavento, TG França, LL Ishikawa, et al.
Faecal examination and PCR to detect Strongyloides venezuelensis in experimentally infected Lewis rats.
Mem Inst Oswaldo Cruz, 105 (2010), pp. 57-61

ORCID ID: 0000-0001-6156-3649

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.6061/clinics/2021/e3528
No mostrar más